Literature DB >> 15121760

The orphan nuclear receptor LRH-1 activates the ABCG5/ABCG8 intergenic promoter.

Lita A Freeman1, Arion Kennedy, Justina Wu, Samantha Bark, Alan T Remaley, Silvia Santamarina-Fojo, H Bryan Brewer.   

Abstract

The ATP binding cassette (ABC) half-transporters ABCG5 and ABCG8 facilitate biliary and intestinal removal of neutral sterols. Here, we identify a binding site for the orphan nuclear receptor liver receptor homolog-1 (LRH-1) at nt 134-142 of the ABCG5/ABCG8 intergenic region necessary for the activity of both the ABCG5 and ABCG8 promoters. Mutating this LRH-1 binding site reduced promoter activity of the human ABCG5/ABCG8 intergenic region more than 7-fold in HepG2 and Caco2 cells. Electrophoretic mobility shift assays with HepG2 nuclear extracts demonstrated specific binding of LRH-1 to the LRH-1 binding motif in the human ABCG5/ABCG8 intergenic region. LRH-1 overexpression increased promoter activity up to 1.6-fold and 3-fold in Caco2 and 293 cells, respectively. Finally, deoxycholic acid repressed the ABCG5 and ABCG8 promoters, consistent with bile acid regulation via the farnesoid X receptor-small heterodimeric partner-LRH-1 pathway. These results demonstrate that LRH-1 is a positive transcription factor for ABCG5 and ABCG8 and, in conjunction with studies on LRH-1 activation of other promoters, identify LRH-1 as a "master regulator" for genes involved in sterol and bile acid secretion from liver and intestine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121760     DOI: 10.1194/jlr.C400002-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  31 in total

Review 1.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 2.  Emerging actions of the nuclear receptor LRH-1 in the gut.

Authors:  Pablo J Fernandez-Marcos; Johan Auwerx; Kristina Schoonjans
Journal:  Biochim Biophys Acta       Date:  2010-12-29

3.  LRH-1-dependent glucose sensing determines intermediary metabolism in liver.

Authors:  Maaike H Oosterveer; Chikage Mataki; Hiroyasu Yamamoto; Taoufiq Harach; Norman Moullan; Theo H van Dijk; Eduard Ayuso; Fatima Bosch; Catherine Postic; Albert K Groen; Johan Auwerx; Kristina Schoonjans
Journal:  J Clin Invest       Date:  2012-07-09       Impact factor: 14.808

4.  Opposing Gatekeepers of Apical Sterol Transport: Niemann-Pick C1-Like 1 (NPC1L1) and ATP-Binding Cassette Transporters G5 and G8 (ABCG5/ABCG8).

Authors:  J Mark Brown; Liqing Yu
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2009-03

5.  Liver receptor homolog 1 is a negative regulator of the hepatic acute-phase response.

Authors:  Nicolas Venteclef; Jason C Smith; Bryan Goodwin; Philippe Delerive
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

6.  LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease.

Authors:  Agnes Coste; Laurent Dubuquoy; Romain Barnouin; Jean-Sebastien Annicotte; Benjamin Magnier; Mario Notti; Nadia Corazza; Maria Cristina Antal; Daniel Metzger; Pierre Desreumaux; Thomas Brunner; Johan Auwerx; Kristina Schoonjans
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-01       Impact factor: 11.205

7.  alpha(1)-fetoprotein transcription factor (FTF)/liver receptor homolog-1 (LRH-1) is an essential lipogenic regulator.

Authors:  Zhumei Xu; Lingli Ouyang; Antonio Del Castillo-Olivares; William M Pandak; Gregorio Gil
Journal:  Biochim Biophys Acta       Date:  2009-12-28

Review 8.  Protein mediators of sterol transport across intestinal brush border membrane.

Authors:  J Mark Brown; Liqing Yu
Journal:  Subcell Biochem       Date:  2010

Review 9.  Role of the gut in lipid homeostasis.

Authors:  Nada A Abumrad; Nicholas O Davidson
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

Review 10.  ABCG5 and ABCG8: more than a defense against xenosterols.

Authors:  Shailendra B Patel; Gregory A Graf; Ryan E Temel
Journal:  J Lipid Res       Date:  2018-05-04       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.